These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 22894615)

  • 61. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae.
    Dallenne C; Da Costa A; Decré D; Favier C; Arlet G
    J Antimicrob Chemother; 2010 Mar; 65(3):490-5. PubMed ID: 20071363
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
    Jayahar Bharathi M; Ramakrishnan R; Ramesh S; Murugan N
    Ophthalmic Res; 2012; 47(1):52-6. PubMed ID: 21720185
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Carbapenem-hydrolyzing gram-negative bacteria: current options for treatment and review of drugs in development.
    Abandeh FI; Drew ME; Sopirala MM
    Recent Pat Antiinfect Drug Discov; 2012 Apr; 7(1):19-27. PubMed ID: 22211694
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Suto S; Zagar Z
    Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The continuing challenge of ESBLs.
    Perez F; Endimiani A; Hujer KM; Bonomo RA
    Curr Opin Pharmacol; 2007 Oct; 7(5):459-69. PubMed ID: 17875405
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae.
    Livermore DM; Mushtaq S; Nguyen T; Warner M
    Int J Antimicrob Agents; 2011 May; 37(5):405-9. PubMed ID: 21276715
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Patterns of resistance to beta-lactams and characterization of beta-lactamases in Escherichia coli isolates from children in Tunisia.
    Réjiba S; Kechrid A
    J Chemother; 2007 Aug; 19(4):382-7. PubMed ID: 17855181
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Detection of TEM, SHV and CTX-M in Mymensingh region in Bangladesh.
    Yasmin T; Hossain MA; Paul SK; Sarkar SR; Kabir MR; Rahman MM; Sultana S; Mowla G; Zahan NA
    Mymensingh Med J; 2013 Jul; 22(3):465-72. PubMed ID: 23982534
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The evolution of beta-lactamases.
    Bush K
    Ciba Found Symp; 1997; 207():152-63; discussion 163-6. PubMed ID: 9189640
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Study on prevalence and molecular mechanisms of antibacterial resistance in Gram-negative pathogens of nosocomial infections in hospitals of Moscow and Perm'].
    Mudrak DE; Ikriannikova LN; Sidorenko SV; Il'ina EN
    Antibiot Khimioter; 2007; 52(7-8):10-6. PubMed ID: 18986019
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms.
    Gniadkowski M
    Clin Microbiol Infect; 2001 Nov; 7(11):597-608. PubMed ID: 11737084
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Metallo-beta-lactamases: the quiet before the storm?
    Walsh TR; Toleman MA; Poirel L; Nordmann P
    Clin Microbiol Rev; 2005 Apr; 18(2):306-25. PubMed ID: 15831827
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Detection of beta-lactamase-mediated resistance.
    Livermore DM; Brown DF
    J Antimicrob Chemother; 2001 Jul; 48 Suppl 1():59-64. PubMed ID: 11420337
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bench-to-bedside review: The role of beta-lactamases in antibiotic-resistant Gram-negative infections.
    Bush K
    Crit Care; 2010; 14(3):224. PubMed ID: 20594363
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Metallo-beta-lactamases of Pseudomonas aeruginosa--a novel mechanism resistance to beta-lactam antibiotics.
    Sacha P; Wieczorek P; Hauschild T; Zórawski M; Olszańska D; Tryniszewska E
    Folia Histochem Cytobiol; 2008; 46(2):137-42. PubMed ID: 18519228
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Molecular basis of antibiotic resistance and beta-lactamase inhibition by mechanism-based inactivators: perspectives and future directions.
    Therrien C; Levesque RC
    FEMS Microbiol Rev; 2000 Jul; 24(3):251-62. PubMed ID: 10841972
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multiparametric determination of genes and their point mutations for identification of beta-lactamases.
    Rubtsova MY; Ulyashova MM; Bachmann TT; Schmid RD; Egorov AM
    Biochemistry (Mosc); 2010 Dec; 75(13):1628-49. PubMed ID: 21417998
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Extended spectrum β-lactamases, carbapenemases and mobile genetic elements responsible for antibiotics resistance in Gram-negative bacteria.
    El Salabi A; Walsh TR; Chouchani C
    Crit Rev Microbiol; 2013 May; 39(2):113-22. PubMed ID: 22667455
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evolving trends of New Delhi Metallo-betalactamse (NDM) variants: A threat to antimicrobial resistance.
    Farhat N; Khan AU
    Infect Genet Evol; 2020 Dec; 86():104588. PubMed ID: 33038522
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli.
    Pitout JD; Sanders CC; Sanders WE
    Am J Med; 1997 Jul; 103(1):51-9. PubMed ID: 9236486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.